Heavily Treatment-Experienced Patients and Management of Multi-Drug Resistant HIV-1 Infections : Episode 8

Treatment Options for Heavily Treatment-Experienced Patients with Multi-Drug Resistant HIV

November 25, 2022

By Joseph Eron, MD
Daniel R. Kuritzkes, MD

Video

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, explore the relative pros and cons of various agents and drug classes that may be used for the treatment of multi-drug resistant HIV.

EP: 1.Prevalence and Challenges Associated With Multi-Drug Resistant HIV Infections

EP: 2.Understanding Risks of Developing Multi-Drug Resistant HIV

EP: 3.The Impact of Drug Resistance on Treatment Efficacy

EP: 4.Approaches to Initial Treatment Selection

EP: 5.Discussing HIV Drug Resistance With Patients

EP: 6.Managing Patients With Suboptimal Treatment Response

EP: 7.Exploring the State of HIV Resistance Testing

Now Viewing

EP: 8.Treatment Options for Heavily Treatment-Experienced Patients with Multi-Drug Resistant HIV

EP: 9.Challenges and Limitations of Current Regimens for Multidrug-Resistant HIV

EP: 10.Mechanisms and Clinical Use of Lenacapavir for Multidrug-Resistant HIV

EP: 11.Clinical Implications of New Data for Fostemsavir and Ibalizumab for Heavily Treatment-Experienced Patients With HIV

EP: 12.High-Resistance Therapy Options for Treatment-Naïve Patients With HIV

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Subscribe Now!